P1679: HEALTH-RELATED QUALITY OF LIFE IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM) TREATED WITH ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR): RESULTS FROM THE PHASE 3 ASPEN TRIAL LONG-TERM FOLLOW-UP

• Alessandra Tedeschi,
• Constantine Tam,
• Roger Owen,
• Christian Buske,
• Véronique Leblond,
• Meletios A. Dimopoulos,
• Ramón García-Sanz,
• Jorge Castillo,
• Judith Trotman,
• Steven Treon,
• Keri Yang,
• Boxiong Tang,
• Heather Allewelt,
• Sheel Patel,
• Wai Chan,
• Aileen Cohen,
• Jingjing Yan Schneider,
• Gisoo Barnes

Affiliations

Alessandra Tedeschi

1 ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

Constantine Tam

2 Alfred Health and Monash University, Melbourne, Australia

Roger Owen

3 St. James University Hospital, Leeds, United Kingdom

Christian Buske

4 Institute of Experimental Cancer Research, CCCU, University Hospital Ulm, Baden-Württemberg, Germany

Véronique Leblond

5 Sorbonne University, Pitié Salpêtrière Hospital, Paris, France

Meletios A. Dimopoulos

6 National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Ramón García-Sanz

7 Hospital Universitario de Salamanca, Salamanca, Spain

Jorge Castillo

8 Dana-Farber Cancer Institute, Boston, United States

Judith Trotman

9 Concord Repatriation General Hospital, Sydney, New South Wales, Australia

Steven Treon

8 Dana-Farber Cancer Institute, Boston, United States

Keri Yang

10 BeiGene USA, Inc., San Mateo, United States

Boxiong Tang

10 BeiGene USA, Inc., San Mateo, United States

Heather Allewelt

10 BeiGene USA, Inc., San Mateo, United States

Sheel Patel

10 BeiGene USA, Inc., San Mateo, United States

Wai Chan

10 BeiGene USA, Inc., San Mateo, United States

Aileen Cohen

10 BeiGene USA, Inc., San Mateo, United States

Jingjing Yan Schneider

10 BeiGene USA, Inc., San Mateo, United States

Gisoo Barnes

10 BeiGene USA, Inc., San Mateo, United States